entertainment -WSS

entertainment

author：focus 2025-08-12 09:08:28 - browse：622

Devoted Health sign -- health policy coverage from STAT — Courtesy Devoted Health

Devoted Health has been one of the most prominent health insurance and provider startups of the past decade — founded and overseen by several alumni of former President Barack Obama’s administration.

But it has not turned a profit after five years of selling Medicare Advantage plans to older adults, according to a STAT analysis of Devoted’s financial filings. And Devoted isn’t sharing many details about its progress, either.

Health insurance companies take a while to reach profitability because they need to enroll a lot of people, which then allows them to spread medical costs across a bigger pool. But Devoted’s persistent losses raise questions if it, too, will follow the paths of other younger, troubled insurance startups — like Alignment Healthcare, Bright Health, Clover Health, and Oscar Health — that have promised better care while collectively burning through billions of dollars. Most of those other companies have exited or scaled back their participation in various insurance programs, upending the health coverage of millions of people.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Medicare’s new pay boost for primary care is angering specialists

hotspot

WSS

New weight loss drugs work. But how can they best be used?

Feng Zhang CRISPR delivery startup lays off quarter of staff

How state and local governments are sidelining science

UCB departs biotech trade group BIO

Ohio still needs to do more to protect the right to abortion

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

focus

entertainment

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

New weight loss drugs work. But how can they best be used?

Jerome Adams on the need for new antivirals for Covid

Ohio still needs to do more to protect the right to abortion

What does generative AI mean for health care? We asked experts

3 medical device trends to watch in 2024

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Study suggests Covid rebound is far more common with Paxlovid than without

Duchenne breakthrough therapy leaves behind pioneering families

J&J to buy cancer drug developer Ambrx Biopharma

hotspot

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Experimental asthma app from Apple and Anthem shows promise

GSK Flovent asthma inhalers replaced by authorized generics

Ahead of JPM, here's who's profiting most in health care

AdventHealth escalates lawsuit against insurance vendor Multiplan

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

entertainment

hotspot

focus

entertainment